sentences:  In a phase 2 clinical trial, mapatumumab was well tolerated and could be administered safely in patients with advanced non-small-cell lung cancer (NSCLC) and advanced colorectal cancer.Stable disease was observed in a number of NSCLC patients.In two phase 1b clinical trials mapatumumab in combination with chemotherapy was well tolerated by patients with advanced solid tumors.